Israel - Hospital Average Length of Stay for Hyperplasia of Prostate
Since 2014, Israel Hospital Average Length of Stay for Hyperplasia of Prostate decreased by 0.5% year on year. At 3.8 Days in 2019, the country was number 20 among other countries in Hospital Average Length of Stay for Hyperplasia of Prostate. Lithuania topped the ranking with 6.1 Days in 2019, a decrease of 1.6% compared to 2018. Slovenia recorded the best 5 years average growth at +4.6% per year, while Netherlands recorded the worst performance at -6.8% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 3.80 |
| 2018 | 3.80 |
| 2017 | 4.10 |
| 2016 | 3.80 |
| 2015 | 3.90 |
Download all data from 2000 to 2019
How does Israel rank in Hospital Average Length of Stay for Hyperplasia of Prostate?
| # | 33 Countries | Days | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Lithuania
|
6.10 | 2019 | -1.6 % | -1.0 % | View data | |
| 1 |
#1
South Korea
|
6.10 | 2019 | -1.6 % | -1.0 % | View data | |
| 19 |
#19
France
|
4.00 | 2019 | -2.4 % | -4.4 % | View data | |
| 20 |
#20
Israel
|
3.80 | 2019 | +0.0 % | -0.5 % | View data | |
| 20 |
#20
Turkey
|
3.80 | 2019 | +0.0 % | +0.0 % | View data | |